Vivani Medical, Inc. VANI

VANI Company Overview

Vivani Medical, Inc. is a clinical-stage biopharmaceutical and medical technology company focused on developing long-acting implantable drug delivery therapies for chronic diseases. The company operates primarily in the healthcare, biotechnology, and drug delivery device industries, with a strategic emphasis on metabolic diseases such as obesity and type 2 diabetes. Vivani’s core platform technologies are designed to provide sustained, subdermal therapeutic delivery over extended periods, potentially improving medication adherence and reducing dosing frequency compared with traditional injectable therapies.

The company’s principal business lines center on its proprietary NanoPortal implant technology and related therapeutic development programs. Its lead development efforts have focused on GLP-1 receptor agonist therapies for obesity and diabetes management. Vivani evolved from prior iterations of implantable drug delivery and neurostimulation businesses, including corporate restructuring activities associated with legacy entities in the medical device sector. The company has positioned itself as a differentiated player in long-duration therapeutic implants by combining drug-device engineering with chronic disease management applications.